-
Mashup Score: 0
Combination treatment with retifanlimab, bevacizumab, and hypofractionated radiotherapy — with or without epacadostat — warrants further investigation, according to researchers.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet
Treatment with retifanlimab, bevacizumab, and hypofractionated radiotherapy — with or without epacadostat — appears safe and effective in patients with recurrent #glioblastoma. Presented at #SNO24, reported by @CancerTherAdvsr. https://t.co/Laz19EO6Av